Skip to main navigation Skip to search Skip to main content

Suppression of the normal mouse c-myc oncogene in human lymphoma cells

  • Salvatore Feo
  • , Abbas Ar-Rushdi
  • , Kay Huebner
  • , Janet Finan
  • , Peter C. Nowell
  • , Bayard Clarkson
  • , Carlo M. Croce

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

In Burkitt's lymphoma, which carries the t(8;14) chromosome translocation, the c-myc oncogene normally located on band q24 of human chromosome 8 (refs 1-3) translocates to the heavy-chain locus on chromosome 14 (refs 1,4,5); this results in transcriptional deregulation of the translocated c-myc oncogene, which is transcribed constitutively at elevated levels5-9, while the normal c-myc oncogene on the uninvolved chromosome 8 is either silent 6-11 or expressed at very low levels (A.ar-R. and C.M.C., unpublished results). We have now introduced the active c-myc oncogene of proliferating mouse spleen cells into human lymphoma cells carrying the t(8;14) chromosome translocation by hydridization, and have examined the hybrids for expression of the human and murine c-myc oncogene. The results of this analysis, reported here, indicate that the active mouse myc gene is shut off at the transcriptional level in the human lymphoma cells, implying that human B cells at the stage of differentiation of lymphoma cells used in this study are nonpermissive for normal c-myc transcription.

Original languageEnglish
Pages (from-to)493-495
Number of pages3
JournalNature
Volume313
Issue number6002
DOIs
StatePublished - 1985
Externally publishedYes

Fingerprint

Dive into the research topics of 'Suppression of the normal mouse c-myc oncogene in human lymphoma cells'. Together they form a unique fingerprint.

Cite this